Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Johanna

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Toxicology|July 25, 2024
Bioactivation of cinnamic alcohol in a reconstructed human epidermis model and evaluation of sensitizing potency of the identified metabolitesLorena Ndreu, Josefine Carlsson, David J Ponting, et al.
ACS Chemical Neuroscience|November 10, 2021
Novel Thienopyrimidine-Based PET Tracers for P2Y<sub>12</sub> Receptor Imaging in the BrainBerend van der Wildt, Bieneke Janssen, Aleksandra Pekošak, et al.
American Journal of Medical Genetics. Part A|June 5, 2003
Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testingLitanja Lodder, Petra G Frets, R Willem Trijsburg, et al.
Journal of Medicinal Chemistry|September 15, 2023
Development of <sup>18</sup>F-Labeled PET Tracer Candidates for Imaging of the Abelson Non-receptor Tyrosine Kinase in Parkinson's DiseaseE Johanna L Stéen, A Yeong Park, Wissam Beaino, et al.
Chemmedchem|August 11, 2025
Exploration of Fluorinated Pyrazolidine-3,5-Diones for Positron Emission Tomography Imaging of the P2Y<sub>12</sub> Receptor in the Central Nervous SystemE Johanna L Stéen, Anne van der Schatte Olivier, Berend van der Wildt, et al.
Biochemical Pharmacology|April 3, 2025
Characterization of [<sup>3</sup>H]AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y<sub>12</sub> receptorE Johanna L Stéen, Efthalia-Natalia Tousiaki, Lee Kingston, et al.
ACS Nano|December 11, 2019
<i>Trans</i>-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear ImagingE Johanna L Stéen, Jesper T Jørgensen, Kerstin Johann, et al.
Breast Cancer Research and Treatment|June 29, 2002
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)Litanja N Lodder, Petra G Frets, R Willem Trijsburg, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted <i>In Vivo</i> ChemistryE Johanna L Stéen, Jesper T Jørgensen, Christoph Denk, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2019
Improved radiosynthesis and preliminary in vivo evaluation of the <sup>11</sup>C-labeled tetrazine [<sup>11</sup>C]AE-1 for pretargeted PET imagingE Johanna L Stéen, Jesper T Jørgensen, Ida N Petersen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Toxicology|July 25, 2024
Bioactivation of cinnamic alcohol in a reconstructed human epidermis model and evaluation of sensitizing potency of the identified metabolitesLorena Ndreu, Josefine Carlsson, David J Ponting, et al.
ACS Chemical Neuroscience|November 10, 2021
Novel Thienopyrimidine-Based PET Tracers for P2Y<sub>12</sub> Receptor Imaging in the BrainBerend van der Wildt, Bieneke Janssen, Aleksandra Pekošak, et al.
American Journal of Medical Genetics. Part A|June 5, 2003
Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testingLitanja Lodder, Petra G Frets, R Willem Trijsburg, et al.
Journal of Medicinal Chemistry|September 15, 2023
Development of <sup>18</sup>F-Labeled PET Tracer Candidates for Imaging of the Abelson Non-receptor Tyrosine Kinase in Parkinson's DiseaseE Johanna L Stéen, A Yeong Park, Wissam Beaino, et al.
Chemmedchem|August 11, 2025
Exploration of Fluorinated Pyrazolidine-3,5-Diones for Positron Emission Tomography Imaging of the P2Y<sub>12</sub> Receptor in the Central Nervous SystemE Johanna L Stéen, Anne van der Schatte Olivier, Berend van der Wildt, et al.
Biochemical Pharmacology|April 3, 2025
Characterization of [<sup>3</sup>H]AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y<sub>12</sub> receptorE Johanna L Stéen, Efthalia-Natalia Tousiaki, Lee Kingston, et al.
ACS Nano|December 11, 2019
<i>Trans</i>-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear ImagingE Johanna L Stéen, Jesper T Jørgensen, Kerstin Johann, et al.
Breast Cancer Research and Treatment|June 29, 2002
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)Litanja N Lodder, Petra G Frets, R Willem Trijsburg, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted <i>In Vivo</i> ChemistryE Johanna L Stéen, Jesper T Jørgensen, Christoph Denk, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2019
Improved radiosynthesis and preliminary in vivo evaluation of the <sup>11</sup>C-labeled tetrazine [<sup>11</sup>C]AE-1 for pretargeted PET imagingE Johanna L Stéen, Jesper T Jørgensen, Ida N Petersen, et al.
Pageof 2